{"id":18612,"date":"2020-12-14T17:16:23","date_gmt":"2020-12-14T16:16:23","guid":{"rendered":"https:\/\/www.hollandbio.nl\/?p=18612"},"modified":"2020-12-14T17:16:24","modified_gmt":"2020-12-14T16:16:24","slug":"protinhi-therapeutics-sluit-zich-aan-bij-johnson-johnson-innovation-jlabs","status":"publish","type":"post","link":"https:\/\/www.hollandbio.nl\/en\/nieuws\/protinhi-therapeutics-sluit-zich-aan-bij-johnson-johnson-innovation-jlabs\/","title":{"rendered":"Protinhi Therapeutics sluit zich aan bij Johnson &#038; Johnson Innovation \u2013 JLABS"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Protinhi Therapeutics ontwikkelt antivirale middelen op basis van een bewezen werkingsmechanisme bij ziekten zoals HIV en Hepatitis C. De door Protinhi geleide programma\u2019s richten zich op dengue en gerelateerde virale ziekten zoals Zika en West-Nijl virus. De huidige COVID-19 pandemie heeft het belang aangetoond van het ontwikkelen van strategie\u00ebn tegen dreigende virusziekten. Het Nijmeegse biotechbedrijf gaat nu de samenwerking aan met Johnson &amp; Johnson Innovation \u2013 JLABS.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Johnson &amp; Johnson Innovation \u2013 JLABS is een vooraanstaand life science incubatorprogramma met een wereldwijd netwerk van open innovatie-ecosystemen, dat innovators in staat stelt de levering van levensbevorderende gezondheids- en welzijnsoplossingen aan pati\u00ebnten over de hele wereld te cre\u00ebren en te versnellen. Als leider in innovatie helpt JLABS ondernemers in de farmacie, medische apparatuur, consumenten en gezondheidstechnologie om potenti\u00eble oplossingen voor de gezondheidszorg te bieden aan pati\u00ebnten en consumenten.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Door zich aan te sluiten bij het JLABS-netwerk zal <a href=\"https:\/\/www.protinhi.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">Protinhi Therapeutics<\/a> de levering van hun gepatenteerde samenstellingen in nieuwe geneesmiddelen verder kunnen versnellen met als doel de huidige hoge onvervulde medische behoefte tegen aankomende virusziekten zoals COVID-10, knokkelkoorts en het West-Nijlvirus aan te pakken.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u201cDeel uitmaken van het Johnson &amp; Johnson Innovation \u2013 JLABS ecosysteem is een grote en spannende stap voor ons, we geloven dat het onze R&amp;D inspanningen zal versterken en ons toegang zal geven tot de extra expertise en het mentorschap\u201d, aldus Dr. Bernd van Buuren, mede-oprichter en CEO van Protinhi Therapeutics. \u201cProtinhi heeft de kracht en de schaalbaarheid van haar technologieplatform kunnen aantonen door krachtige aanknopingspunten te hebben tegen Corona. We hebben veelbelovende resultaten die geblokkeerde virusreplicatie aantonen in cellulaire modellen voor dengue, West-Nijl en SARS-CoV2. Dit toont het potentieel van de verbindingen als breed-spectrum antivirale middelen aan. Ons team heeft de competentie en ervaring om ze te ontwikkelen tot innovatieve antivirale middelen.\u201d<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Bron: Protinhi Therapeutics (<a href=\"https:\/\/noviotechcampus.com\/nl\/2020\/12\/10\/protinhi-therapeutics-sluit-aan-bij-johnson-johnson-innovation-jlabs\/\">Persbericht<\/a>)<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Protinhi Therapeutics ontwikkelt antivirale middelen op basis van een bewezen werkingsmechanisme bij ziekten zoals HIV en Hepatitis C. De door Protinhi geleide programma\u2019s richten zich op dengue en gerelateerde virale ziekten zoals Zika en West-Nijl virus. De huidige COVID-19 pandemie heeft het belang aangetoond van het ontwikkelen van strategie\u00ebn tegen dreigende virusziekten. Het Nijmeegse biotechbedrijf [&hellip;]<\/p>\n","protected":false},"author":16,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[43],"tags":[],"class_list":["post-18612","post","type-post","status-publish","format-standard","hentry","category-innovatieklimaat"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Protinhi Therapeutics sluit zich aan bij Johnson &amp; Johnson Innovation \u2013 JLABS - hollandbio<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.hollandbio.nl\/en\/nieuws\/protinhi-therapeutics-sluit-zich-aan-bij-johnson-johnson-innovation-jlabs\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Protinhi Therapeutics sluit zich aan bij Johnson &amp; Johnson Innovation \u2013 JLABS - hollandbio\" \/>\n<meta property=\"og:description\" content=\"Protinhi Therapeutics ontwikkelt antivirale middelen op basis van een bewezen werkingsmechanisme bij ziekten zoals HIV en Hepatitis C. De door Protinhi geleide programma\u2019s richten zich op dengue en gerelateerde virale ziekten zoals Zika en West-Nijl virus. De huidige COVID-19 pandemie heeft het belang aangetoond van het ontwikkelen van strategie\u00ebn tegen dreigende virusziekten. Het Nijmeegse biotechbedrijf [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.hollandbio.nl\/en\/nieuws\/protinhi-therapeutics-sluit-zich-aan-bij-johnson-johnson-innovation-jlabs\/\" \/>\n<meta property=\"og:site_name\" content=\"hollandbio\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-14T16:16:23+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-12-14T16:16:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2025\/01\/hb-opengraph_illu.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"HollandBIO\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@hollandbio\" \/>\n<meta name=\"twitter:site\" content=\"@hollandbio\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"HollandBIO\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/protinhi-therapeutics-sluit-zich-aan-bij-johnson-johnson-innovation-jlabs\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/protinhi-therapeutics-sluit-zich-aan-bij-johnson-johnson-innovation-jlabs\\\/\"},\"author\":{\"name\":\"HollandBIO\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/person\\\/48824449f08e494bb7ea02e1ff5dd6ea\"},\"headline\":\"Protinhi Therapeutics sluit zich aan bij Johnson &#038; Johnson Innovation \u2013 JLABS\",\"datePublished\":\"2020-12-14T16:16:23+00:00\",\"dateModified\":\"2020-12-14T16:16:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/protinhi-therapeutics-sluit-zich-aan-bij-johnson-johnson-innovation-jlabs\\\/\"},\"wordCount\":312,\"publisher\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#organization\"},\"articleSection\":[\"Innovatieklimaat\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/protinhi-therapeutics-sluit-zich-aan-bij-johnson-johnson-innovation-jlabs\\\/\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/protinhi-therapeutics-sluit-zich-aan-bij-johnson-johnson-innovation-jlabs\\\/\",\"name\":\"Protinhi Therapeutics sluit zich aan bij Johnson & Johnson Innovation \u2013 JLABS - hollandbio\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#website\"},\"datePublished\":\"2020-12-14T16:16:23+00:00\",\"dateModified\":\"2020-12-14T16:16:24+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/protinhi-therapeutics-sluit-zich-aan-bij-johnson-johnson-innovation-jlabs\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/protinhi-therapeutics-sluit-zich-aan-bij-johnson-johnson-innovation-jlabs\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/protinhi-therapeutics-sluit-zich-aan-bij-johnson-johnson-innovation-jlabs\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Protinhi Therapeutics sluit zich aan bij Johnson &#038; Johnson Innovation \u2013 JLABS\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/\",\"name\":\"hollandbio\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#organization\",\"name\":\"hollandbio\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/HollandBIO_logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.hollandbio.nl\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/HollandBIO_logo.svg\",\"width\":218.664,\"height\":29.659,\"caption\":\"hollandbio\"},\"image\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/hollandbio\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/hollandbio\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/person\\\/48824449f08e494bb7ea02e1ff5dd6ea\",\"name\":\"HollandBIO\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Protinhi Therapeutics sluit zich aan bij Johnson & Johnson Innovation \u2013 JLABS - hollandbio","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.hollandbio.nl\/en\/nieuws\/protinhi-therapeutics-sluit-zich-aan-bij-johnson-johnson-innovation-jlabs\/","og_locale":"en_US","og_type":"article","og_title":"Protinhi Therapeutics sluit zich aan bij Johnson & Johnson Innovation \u2013 JLABS - hollandbio","og_description":"Protinhi Therapeutics ontwikkelt antivirale middelen op basis van een bewezen werkingsmechanisme bij ziekten zoals HIV en Hepatitis C. De door Protinhi geleide programma\u2019s richten zich op dengue en gerelateerde virale ziekten zoals Zika en West-Nijl virus. De huidige COVID-19 pandemie heeft het belang aangetoond van het ontwikkelen van strategie\u00ebn tegen dreigende virusziekten. Het Nijmeegse biotechbedrijf [&hellip;]","og_url":"https:\/\/www.hollandbio.nl\/en\/nieuws\/protinhi-therapeutics-sluit-zich-aan-bij-johnson-johnson-innovation-jlabs\/","og_site_name":"hollandbio","article_published_time":"2020-12-14T16:16:23+00:00","article_modified_time":"2020-12-14T16:16:24+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2025\/01\/hb-opengraph_illu.png","type":"image\/png"}],"author":"HollandBIO","twitter_card":"summary_large_image","twitter_creator":"@hollandbio","twitter_site":"@hollandbio","twitter_misc":{"Written by":"HollandBIO","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/protinhi-therapeutics-sluit-zich-aan-bij-johnson-johnson-innovation-jlabs\/#article","isPartOf":{"@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/protinhi-therapeutics-sluit-zich-aan-bij-johnson-johnson-innovation-jlabs\/"},"author":{"name":"HollandBIO","@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/person\/48824449f08e494bb7ea02e1ff5dd6ea"},"headline":"Protinhi Therapeutics sluit zich aan bij Johnson &#038; Johnson Innovation \u2013 JLABS","datePublished":"2020-12-14T16:16:23+00:00","dateModified":"2020-12-14T16:16:24+00:00","mainEntityOfPage":{"@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/protinhi-therapeutics-sluit-zich-aan-bij-johnson-johnson-innovation-jlabs\/"},"wordCount":312,"publisher":{"@id":"https:\/\/www.hollandbio.nl\/en\/#organization"},"articleSection":["Innovatieklimaat"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/protinhi-therapeutics-sluit-zich-aan-bij-johnson-johnson-innovation-jlabs\/","url":"https:\/\/www.hollandbio.nl\/en\/nieuws\/protinhi-therapeutics-sluit-zich-aan-bij-johnson-johnson-innovation-jlabs\/","name":"Protinhi Therapeutics sluit zich aan bij Johnson & Johnson Innovation \u2013 JLABS - hollandbio","isPartOf":{"@id":"https:\/\/www.hollandbio.nl\/en\/#website"},"datePublished":"2020-12-14T16:16:23+00:00","dateModified":"2020-12-14T16:16:24+00:00","breadcrumb":{"@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/protinhi-therapeutics-sluit-zich-aan-bij-johnson-johnson-innovation-jlabs\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.hollandbio.nl\/en\/nieuws\/protinhi-therapeutics-sluit-zich-aan-bij-johnson-johnson-innovation-jlabs\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/protinhi-therapeutics-sluit-zich-aan-bij-johnson-johnson-innovation-jlabs\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.hollandbio.nl\/en\/"},{"@type":"ListItem","position":2,"name":"Protinhi Therapeutics sluit zich aan bij Johnson &#038; Johnson Innovation \u2013 JLABS"}]},{"@type":"WebSite","@id":"https:\/\/www.hollandbio.nl\/en\/#website","url":"https:\/\/www.hollandbio.nl\/en\/","name":"hollandbio","description":"","publisher":{"@id":"https:\/\/www.hollandbio.nl\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.hollandbio.nl\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.hollandbio.nl\/en\/#organization","name":"hollandbio","url":"https:\/\/www.hollandbio.nl\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2023\/08\/HollandBIO_logo.svg","contentUrl":"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2023\/08\/HollandBIO_logo.svg","width":218.664,"height":29.659,"caption":"hollandbio"},"image":{"@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/hollandbio","https:\/\/www.linkedin.com\/company\/hollandbio\/"]},{"@type":"Person","@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/person\/48824449f08e494bb7ea02e1ff5dd6ea","name":"HollandBIO"}]}},"_links":{"self":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/posts\/18612","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/comments?post=18612"}],"version-history":[{"count":0,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/posts\/18612\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/media?parent=18612"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/categories?post=18612"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/tags?post=18612"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}